Search Results

Effects of omalizumab on markers of inflammation in patients with allergic asthma

Authors: Holgate, S.; Smith, N.; Massanari, M.; Jimenez, P.

Source: Allergy, Volume 64, Number 12, December 2009 , pp. 1728-1736(9)

Publisher: Blackwell Publishing

Relationship between pretreatment specific IgE and the response to omalizumab therapy

Authors: Wahn, U.; Martin, C.; Freeman, P.; Blogg, M.; Jimenez, P.

Source: Allergy, Volume 64, Number 12, December 2009 , pp. 1780-1787(8)

Publisher: Blackwell Publishing

Omalizumab: Churg-Strauss syndrome: case report

Source: Reactions, Volume 1, Number 1274, 2009-10-17 , pp. 31-32(2)

Publisher: Adis International

Efficacy and safety of omalizumab in an Asian population with moderate-to-severe persistent asthma

Authors: OHTA, Ken; MIYAMOTO, Terumasa; AMAGASAKI, Taro; YAMAMOTO, Manabu

Source: Respirology, Volume 14, Number 8, November 2009 , pp. 1156-1165(10)

Publisher: Blackwell Publishing

The size of the disease relevant IgE antibody fraction in relation to `total-IgE' predicts the efficacy of anti-IgE (Xolair^®) treatment

Authors: Johansson, S. G. O.; Nopp, A.; Öman, H.; Ankerst, J.; Cardell, L. O.; Grönneberg, R.; Matsols, H.; Rudblad, S.; Strand, V.; Stålenheim, G.

Source: Allergy, Volume 64, Number 10, October 2009 , pp. 1472-1477(6)

Publisher: Blackwell Publishing

First analysis of pharma uptake after NICE approval

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 587, 2009-09-19 , pp. 5-5(1)

Publisher: Adis International

Efficacy of omalizumab in cat-allergic patients with moderate-to-severe persistent asthma

Authors: Massanari, Marc; Kianifard, Farid; Zeldin, Robert K.; Geba, Gregory P.

Source: Allergy and Asthma Proceedings, Volume 30, Number 5, September/October 2009 , pp. 534-539(6)

Publisher: OceanSide Publications, Inc

Baseline characteristics of patients enrolled in EXCELS: a cohort study

Authors: Long, Aidan A.; Fish, James E.; Rahmaoui, Abdelkader; Miller, Mary K.; Bradley, Mary S.; Taki, Hassan N.; Demeo, Anthony N.; Tilles, Stephen A.; Szefler, Stanley J.

Source: Annals of Allergy, Asthma and Immunology, Volume 103, Number 3, September 2009 , pp. 212-219(8)

Publisher: American College of Allergy, Asthma, & Immunology

THE SAFETY OF OMALIZUMAB THERAPY IN A PATIENT WITH SEVERE PERSISTENT ALLERGIC ASTHMA AND HEPATITIS C

Authors: Antonicelli, Leonardo; Stagnozzi, Giorgia; Giuliodoro, Simona; Abbruzzetti, Alessandra; Massaccesi, Chiara

Source: Annals of Allergy, Asthma and Immunology, Volume 103, Number 3, September 2009 , pp. 269-270(2)

Publisher: American College of Allergy, Asthma, & Immunology

Prolonged high-dose omalizumab is required to control reactions to venom immunotherapy in mastocytosis

Authors: Kontou-Fili, K.; Filis, C. I.

Source: Allergy, Volume 64, Number 9, September 2009 , pp. 1384-1385(2)

Publisher: Blackwell Publishing

Eosinophilic pneumonia in an asthmatic patient treated with omalizumab therapy: forme-fruste of Churg-Strauss syndrome?

Authors: Cazzola, M.; Mura, M.; Segreti, A.; Mattei, M. A.; Rogliani, P.

Source: Allergy, Volume 64, Number 9, September 2009 , pp. 1389-1390(2)

Publisher: Blackwell Publishing

Health Canada reviews safety of omalizumab

Source: Reactions, Volume 1, Number 1266, 2009-08-22 , pp. 2-2(1)

Publisher: Adis International

Resolution of Corticosteroid-Induced Diabetes in Allergic Bronchopulmonary Aspergillosis with Omalizumab Therapy: A Novel Approach

Authors: Randhawa, Inderpal; Chin, Terry; Nussbaum, Eliezer

Source: Journal of Asthma, Volume 46, Number 5, June 2009 , pp. 445-447(3)

Publisher: Informa Healthcare

Relationship between omalizumab pharmacokinetics, IgE pharmacodynamics and symptoms in patients with severe persistent allergic (IgE-mediated) asthma

Authors: Lowe, Philip J.; Tannenbaum, Stacey; Gautier, Aurelie; Jimenez, Pablo

Source: British Journal of Clinical Pharmacology, Volume 68, Number 1, July 2009 , pp. 61-76(16)

Publisher: Blackwell Publishing

FDA is reviewing safety of omalizumab

Source: Reactions, Volume 1, Number 1262, 2009-07-25 , pp. 2-2(1)

Publisher: Adis International

Omalizumab: First report of lichen planus: case report

Source: Reactions, Volume 1, Number 1255, 2009-06-06 , pp. 26-26(1)

Publisher: Adis International

Pharmacoeconomic news from ATS

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 580, 2009-06-13 , pp. 5-5(1)

Publisher: Adis International

Off-label use of omalizumab in non-asthma conditions: new opportunities

Authors: Morjaria, Jaymin B; Polosa, Riccardo

Source: Expert Review of Respiratory Medicine, Volume 3, Number 3, June 2009 , pp. 299-308(10)

Publisher: Expert Reviews

A case of severe refractory chronic urticaria: A novel method for evaluation and treatment

Authors: Otto, Hans F.; Calabria, Christopher W.

Source: Allergy and Asthma Proceedings, Volume 30, Number 3, May-June 2009 , pp. 333-337(5)

Publisher: OceanSide Publications, Inc

Tumor Necrosis Factor Inhibitors in Pediatric Asthma

Authors: Gjurow, Daniela; Grzelewski, Tomasz; Sobocinska, Agnieszka; Stelmach, Iwona

Source: Recent Patents on Inflammation & Allergy Drug Discovery, Volume 3, Number 2, June 2009 , pp. 143-148(6)

Publisher: Bentham Science Publishers